Skip to main content

Antonio González Fernández

Institutions of which they are part

Senior researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Antonio González Fernández

Institutions of which they are part

Senior researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Projects

Unitat de Recerca en Malalties Hepatobiliars

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Antonio González Fernández, Lluis Castells Fusté, Silvia Sauleda Oliveras, Lluís Palenzuela Díaz, Maria Buti Ferret, Josep Quer Sivila, Maria Nieves Martell Pérez-Alcalde, Juan Ignacio Esteban Mur, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 54080
Reference: 2009 SGR 383
Duration: 01/01/2010 - 30/04/2014

Utilidad de la PCR bacteriana en el diagnostico de la peritonitis bacteriana espontánea del cirrotico.

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 15205.61
Reference: 01/1390
Duration: 17/07/2001 - 31/12/2002

Estudio longitudinal de la expresión génica diferencial de la alteración vascular esplácnica en el modelo experimental de hipertensión portal de rata. Papel de los mecanismos de angiogénesis

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández, Maria Nieves Martell Pérez-Alcalde
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 83490
Reference: SAF2006-03714
Duration: 01/10/2006 - 30/09/2009

Ministerio de Ciencia

Miocardiopatía del paciente cirrótico: Importancia clínica y relación fisiopatológica con citocinas y óxido nítrico.

IP: Antonio González Fernández
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 39666.8
Reference: 98/1229
Duration: 01/11/1998 - 01/11/1999

Related news

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

Related professionals

Héctor Carmona Díez

Héctor Carmona Díez

Research assistant
Clinical Pharmacology
Read more
Guillem Pons Barcons

Guillem Pons Barcons

Postdoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Sergio Cabello

Sergio Cabello

Research technician
Clinical Neuroimmunology
Read more
Aida Ribera Sole

Aida Ribera Sole

Main researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.